Skip to content

Insider · CIK 0001443705

Simon N.R. Harford

cfoofficer

Files at FOLD (AMICUS THERAPEUTICS, INC.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Apr 27, 2026FOLD
AMICUS THERAPEUTICS, INC.
DDisposition to issuer
Common Stock
-143,595$14.50$2.1M0Apr 27, 2026
Apr 27, 2026FOLD
AMICUS THERAPEUTICS, INC.
DDisposition to issuer
Stock Options (right to buy)derivative
-189,043--0Apr 27, 2026
Apr 27, 2026FOLD
AMICUS THERAPEUTICS, INC.
DDisposition to issuer
Stock Options (right to buy)derivative
-99,073--0Apr 27, 2026
Apr 27, 2026FOLD
AMICUS THERAPEUTICS, INC.
DDisposition to issuer
Stock Options (right to buy)derivative
-150,517--0Apr 27, 2026
Dec 26, 2025FOLD
AMICUS THERAPEUTICS, INC.
FTax withholding
Common Stock
-71,303$14.25$1.0M143,595Dec 30, 2025
Aug 21, 2025FOLD
AMICUS THERAPEUTICS, INC.
FTax withholding
Common Stock
-12,529$7.60$95k214,898Aug 25, 2025
Jan 2, 2025FOLD
AMICUS THERAPEUTICS, INC.
FTax withholding
Common Stock
-7,482$9.31$70k144,354Jan 6, 2025
Jan 3, 2025FOLD
AMICUS THERAPEUTICS, INC.
AGrant or award
Common Stock
+83,073$0.00$0227,427Jan 6, 2025
Jan 3, 2025FOLD
AMICUS THERAPEUTICS, INC.
AGrant or award
Stock Options (right to buy)derivative
+150,517$0.00$0150,517Jan 6, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Simon N.R. Harford: insider trades and track record | InsiderTell